Chemoinformaics analysis of trans-Sabinene hydrate
| Molecular Weight | 154.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 154.136 | nRing | 2 |
| Solubility: LogS | -1.824 | nHRing | 0 |
| Solubility: LogP | 2.44 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 29.5043 |
| nHD | 1 | BPOL | 18.0577 |
| QED | 0.614 |
| Synth | 4.223 |
| Natural Product Likeliness | 3.08 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.009 |
| CACO-2 | -4.329 |
| MDCK | 0.0000234 |
| BBB | 0.778 |
| PPB | 0.710975 |
| VDSS | 1.222 |
| FU | 0.362599 |
| CYP1A2-inh | 0.069 |
| CYP1A2-sub | 0.571 |
| CYP2c19-inh | 0.063 |
| CYP2c19-sub | 0.904 |
| CYP2c9-inh | 0.051 |
| CYP2c9-sub | 0.229 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.365 |
| CYP3a4-inh | 0.155 |
| CYP3a4-sub | 0.299 |
| CL | 14.208 |
| T12 | 0.389 |
| hERG | 0.014 |
| Ames | 0.033 |
| ROA | 0.076 |
| SkinSen | 0.14 |
| Carcinogencity | 0.123 |
| EI | 0.958 |
| Respiratory | 0.112 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.930706 |